Attachment 1 - Proposal Information Form FINAL.pdf

PDF 12 KB Posted

Attached to
Open Market Pharmaceuticals Blanket Purchase Agreement Federal contract opportunity
Solicitation number
IHS-22-03B
Issued by
Department of Health and Human Services Indian Health Service

About this file

This document contains an attachment requesting proposal information from offerors as well as details of an open market blanket purchase agreement solicitation from the Department of Health and Human Services Indian Health Service. The attachment requests identifying and pricing information from offerors, including company name, address, DUNS number, point of contact, and proposed negative distribution fees to be applied to estimated annual purchases of brand name and generic pharmaceutical products totaling between $75 million and $225 million over a potential three-year period. Offerors are also asked to indicate whether their company has a minimum of $1 million in annual pharmaceutical sales. The related solicitation seeks offers to supply pharmaceutical products not available through an existing VA prime vendor contract on a continuous basis to enable treatment of IHS patients nationwide.

View the file

Other files for this federal contract opportunity

Other files attached to Open Market Pharmaceuticals Blanket Purchase Agreement, newest first.
File Type Posted
Amendment 1 - QA FINAL.pdf PDF
Attachment 3 - Facility List FINAL.pdf PDF
OM Pharmaceutical Solicitation FINAL.pdf PDF
Attachment 2 - HHS SubK Plan FINAL.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Attachment #1

Proposal Information Form

Offeror Information:

The following information is required to be filled out and returned with proposal.

Offeror Name:

Offeror Address:

DUNS:

Point of Contact (POC):

POC Email:

POC Telephone:

Pricing Information:

Amounts are based off an estimated total of dollars for the specified period of performance.

These numbers are estimates only and do not bind the government.

BRAND NAME AND

GENERIC

PHARMACEUTICAL

PRODUCTS

ESTIMATED

PURCHASES

NEGATIVE

DISTRIBUTION FEE

TOTAL AMOUNT

(Total estimated purchases x 1 + Proposed negative distribution fee)

BASE PERIOD $75,000,000

OPTION PERIOD 1 $175,000,000

OPTION PERIOD 2 $200,000,000

OPTION PERIOD 3 $225,000,000

Please Answer:

1. Does your company have a minimum of $1 Million dollars in pharmaceutical sales?

Yes No

File details come from the government source that posted it. Updated .